IL1B and infectious otitis media: The content of reduced glutathione in the intestinal tract of the AOM/DSS group was decreased; however, CAPE dose-dependently enhanced glutathione activity and reduced IL-1β, IL-6, and TNF-α levels (Figure 6A).